Veracyte

Veracyte PP&E per Employee

The PP&E per Employee of Veracyte (VCYT) as of Oct 15, 2026 is 40,876.82 USD. In the previous year, PP&E per Employee was 41,246.36 USD — a change of -0.90% (lower).

PP&E per Employee

40,876.82USD

YoY

-0.90%

Last updated:

PP&E per Employee of Veracyte is 2022 40,876.82 USD. PP&E per Employee of Veracyte was 2021 41,246.36 USD. It decreases by -0.90% lower compared to the previous year.

The Veracyte PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2015
13,660.93 USD
Jan 1, 2016
15,205.30 USD
Jan 1, 2017
12,831.79 USD
Jan 1, 2018
11,841.06 USD
Jan 1, 2019
11,831.79 USD
Jan 1, 2020
11,907.28 USD
Jan 1, 2021
41,246.36 USD
Jan 1, 2022
40,876.82 USD
The Veracyte PP&E per Employee history
YEARPP&E per EmployeeYoY
40,876.82USD-0.90%
41,246.36USD+246.40%
11,907.28USD+0.64%
11,831.79USD-0.08%
11,841.06USD-7.72%
12,831.79USD-15.61%
15,205.30USD+11.31%
13,660.93USD+147.87%
5,511.26USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Veracyte Stock analysis

What does Veracyte do? Veracyte Inc is a company that specializes in the development and marketing of diagnostic tests for a wide range of diseases and disorders. The company was founded in 2008 and is headquartered in South San Francisco, California. The history of Veracyte Inc begins with the vision to help patients with better diagnostic options. The company has used its expertise in gene expression technology to develop tests that facilitate the diagnosis of diseases and disorders in various areas, such as cancer, thyroid diseases, and lung diseases. Veracyte Inc's business model is based on selling diagnostic tests to healthcare facilities, hospitals, doctors, and other medical institutions. The tests are performed by specially trained professionals and can provide a precise diagnosis that helps doctors plan individualized treatment. Veracyte Inc is divided into different divisions to offer the best and most precise test for each area. The divisions include cancer diagnosis, thyroid diagnostics, lung diagnostics, and other areas of gene expression technology. In cancer diagnosis, Veracyte Inc offers tests for various types of cancer, such as breast cancer, thyroid cancer, and lung cancer. The tests use RNA sequencing to analyze the patient's genetic information and provide a more precise diagnosis. In thyroid diagnostics, Veracyte Inc offers tests for various thyroid diseases that are often difficult to diagnose. The tests help avoid unnecessary surgeries or medical interventions and enable patients to receive a more accurate diagnosis and treatment. In lung diagnostics, Veracyte Inc offers tests for pneumonia, lung cancer, and other lung diseases. The tests use RNA sequencing and imaging to provide accurate diagnoses that help doctors recommend tailored treatment. In addition to these divisions, Veracyte Inc also offers other products and services, such as information campaigns and training for healthcare professionals, as well as support and counseling for patients and their families. Overall, Veracyte Inc aims to revolutionize the medical field and provide patients with better diagnosis and treatment options. The company's tests offer doctors and patients a more precise and personalized diagnosis, allowing for individualized treatment and achieving the best results. Veracyte is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Veracyte stock

PP&E per Employee of Veracyte is 40,876.82 USD in 2022.

PP&E per Employee of Veracyte changed from 41,246.36 USD to 40,876.82 USD, representing a -0.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee Veracyte since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's Veracyte historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Veracyte

All Key Metrics — Veracyte